231 related articles for article (PubMed ID: 20490538)
1. Pathophysiological roles of WNK kinases in the kidney.
Uchida S
Pflugers Arch; 2010 Sep; 460(4):695-702. PubMed ID: 20490538
[TBL] [Abstract][Full Text] [Related]
2. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
3. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
4. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
[TBL] [Abstract][Full Text] [Related]
5. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
Sohara E; Uchida S
Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
[TBL] [Abstract][Full Text] [Related]
6. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
[TBL] [Abstract][Full Text] [Related]
8. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
9. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.
Chiga M; Rafiqi FH; Alessi DR; Sohara E; Ohta A; Rai T; Sasaki S; Uchida S
J Cell Sci; 2011 May; 124(Pt 9):1391-5. PubMed ID: 21486947
[TBL] [Abstract][Full Text] [Related]
10. Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.
Susa K; Kita S; Iwamoto T; Yang SS; Lin SH; Ohta A; Sohara E; Rai T; Sasaki S; Alessi DR; Uchida S
Clin Exp Nephrol; 2012 Aug; 16(4):530-8. PubMed ID: 22294159
[TBL] [Abstract][Full Text] [Related]
11. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
12. Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension.
Meor Azlan NF; Koeners MP; Zhang J
Acta Pharm Sin B; 2021 May; 11(5):1117-1128. PubMed ID: 34094823
[TBL] [Abstract][Full Text] [Related]
13. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
Vitari AC; Deak M; Morrice NA; Alessi DR
Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
[TBL] [Abstract][Full Text] [Related]
14. The WNK signaling pathway and salt-sensitive hypertension.
Furusho T; Uchida S; Sohara E
Hypertens Res; 2020 Aug; 43(8):733-743. PubMed ID: 32286498
[TBL] [Abstract][Full Text] [Related]
15. Regulation of with-no-lysine kinase signaling by Kelch-like proteins.
Uchida S; Sohara E; Rai T; Sasaki S
Biol Cell; 2014 Feb; 106(2):45-56. PubMed ID: 24313290
[TBL] [Abstract][Full Text] [Related]
16. NCC regulation by WNK signal cascade.
Uchida S; Mori T; Susa K; Sohara E
Front Physiol; 2022; 13():1081261. PubMed ID: 36685207
[TBL] [Abstract][Full Text] [Related]
17. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.
Brown A; Meor Azlan NF; Wu Z; Zhang J
Acta Pharmacol Sin; 2021 Apr; 42(4):508-517. PubMed ID: 32724175
[TBL] [Abstract][Full Text] [Related]
18. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
19. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone.
Chiga M; Rai T; Yang SS; Ohta A; Takizawa T; Sasaki S; Uchida S
Kidney Int; 2008 Dec; 74(11):1403-9. PubMed ID: 18800028
[TBL] [Abstract][Full Text] [Related]
20. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
